Proper supplement use advised for people with, or at risk of, AMD

The Ophthalmology Times Group talked to an optometrist practice about their experience with ocular nutraceuticals

Related Content:

Retina

Brolucizumab for neovascular AMD: Safety guidance and clinician perspectives

The rationale for enabling nurses to inject dexamethasone implants

Addressing gaps in treatment of AMD